Strategic Initiatives Manager
James leads strategic projects across the Nuffield Department of Clinical Neurosciences. These include the Research Excellence Framework, outside appointments/partnerships, conflict of interest, research governance, compliance, data privacy and information security, environmental sustainability, and equality, diversity and inclusivity.
Before joining NDCN late 2022, James spent six years as a Senior Clinical Trial Manager in Sir Peter Horby's group at the Pandemic Sciences Institute, Nuffield Department of Medicine.
James has worked in a Research Governance capacity (with the Research Governance, Ethics and Assurance Team) for University of Oxford sponsored studies, which included monitoring of clinical trials and supporting high-quality research within the University. He had previous coordinating roles at the Oxford Biomedical Research Centre and the Radiology department at the Churchill Hospital.
James is also a qualified exercise therapist and athletics coach, and has undertaken research on the effects of exercise on the behavioural and psychological symptoms of dementia.
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.
Reyes LF. et al, (2023), J Crit Care, 77
Standardized data collection can lead to more insightful outcomes
LEE J., (2023), British Journal of Sports Medicine
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases
Hassoun-Kheir N. et al, (2022), Clinical Microbiology and Infection, 28, 1528 - 1532
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study
Vink E. et al, (2022), Open Forum Infectious Diseases, 9
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
ISARIC Clinical Characterization Group None. et al, (2022), Sci Data, 9